Virology and Antiviral Immunity

Introduction to Virology and Antiviral Immunity

Understanding how viruses replicate and how the immune system counters them is essential for anyone studying biology, medicine, or related fields. This course explores the fundamental concepts behind viral genome types, host transcription mechanisms, innate sensing pathways, viral evasion strategies, latency, and the bridge between innate and adaptive immunity.

1. Viral Genome Types and Replication Requirements

Negative‑sense RNA Viruses

Among RNA viruses, the negative‑sense (RNA‑) genome is unique because it cannot be directly translated into proteins. The virus must first synthesize a complementary positive‑sense RNA strand.

• To accomplish this, the virion packages its own RNA‑dependent RNA polymerase (RdRp) inside the capsid.
• Once the virus enters the host cell, RdRp transcribes the negative‑sense genome into messenger RNA (mRNA), enabling viral protein synthesis.

This requirement distinguishes RNA‑ viruses from positive‑sense RNA viruses, retroviruses, and DNA viruses, which rely on host enzymes or have different replication strategies.

2. Early Transcription of DNA Viruses

Host Cellular RNA Polymerase

DNA viruses, such as adenoviruses and herpesviruses, enter the nucleus of the host cell. During the early phase of infection, they exploit the host's cellular RNA polymerase II to transcribe viral genes.

• This enzyme recognizes viral promoters that often mimic host promoter sequences.
• By using the host transcription machinery, DNA viruses can quickly produce early proteins needed for DNA replication and immune evasion.

Unlike RNA viruses that must bring their own polymerase, DNA viruses rely on the host's polymerase, highlighting a key difference in viral replication strategies.

3. Innate Sensing of Viral RNA

Toll‑Like Receptor 3 (TLR3)

The innate immune system uses pattern‑recognition receptors (PRRs) to detect viral components. TLR3 is specialized for recognizing double‑stranded RNA (dsRNA), a replication intermediate produced by many RNA viruses.

• TLR3 is located in endosomal membranes of dendritic cells, macrophages, and epithelial cells.
• Binding of dsRNA activates the TRIF signaling pathway, leading to production of type I interferons (IFN‑α/β) and pro‑inflammatory cytokines.

Other TLRs, such as TLR7 (single‑stranded RNA) and TLR9 (unmethylated CpG DNA), detect different viral nucleic acids, but TLR3 is the primary sensor for dsRNA.

4. Viral Evasion of RIG‑I Like Receptors

Dengue Virus and 5' Cap Methylation

RIG‑I is a cytosolic RNA sensor that detects uncapped or 5'‑triphosphate RNA, a hallmark of many viral genomes. Dengue virus (a flavivirus) evades detection by methylating the 5' cap of its RNA genome.

• The methylated cap mimics host mRNA, preventing RIG‑I from recognizing the viral RNA as foreign.
• This modification also enhances translation efficiency and protects the viral RNA from degradation.

Other viruses employ strategies such as producing decoy receptors, degrading RIG‑I, or sequestering RNA within protein complexes, but cap methylation is a hallmark of flavivirus immune evasion.

5. DNA Viruses Capable of Latency

Herpesviridae

Among the viral families listed, the herpesvirus family is a DNA virus renowned for establishing lifelong latency.

• After primary infection, herpesviruses persist as episomal DNA in host neurons or other long‑lived cells.
• Latency allows the virus to evade immune detection and reactivate periodically, causing recurrent disease.
• Examples include Herpes Simplex Virus (HSV‑1/2), Varicella‑Zoster Virus (VZV), and Epstein‑Barr Virus (EBV).

In contrast, filoviruses (e.g., Ebola), orthomyxoviruses (e.g., influenza), and retroviruses have different replication cycles and do not establish latency in the same manner.

6. Complement Activation and Adaptive Immunity

Enhancement of TH1 Differentiation and B‑Cell Activation

When viral particles trigger the complement cascade, the resulting opsonins (C3b) and anaphylatoxins (C3a, C5a) have profound effects on the adaptive immune response.

• Complement opsonization improves antigen presentation by dendritic cells, favoring a TH1‑type response that promotes cytotoxic T‑lymphocyte activity.
• Complement fragments also act as costimulatory signals for B cells, enhancing antibody production and class switching.
• Thus, complement activation bridges innate detection with a robust adaptive response, rather than merely suppressing cytokines or inducing regulatory T cells.

7. Interferon Production by Plasmacytoid Dendritic Cells

Type I Interferon α (IFN‑α)

Plasmacytoid dendritic cells (pDCs) are the principal source of IFN‑α during the early stages of viral infection.

• Upon sensing viral nucleic acids via TLR7/9, pDCs rapidly secrete large quantities of IFN‑α.
• IFN‑α establishes an antiviral state in neighboring cells, up‑regulating interferon‑stimulated genes (ISGs) that inhibit viral replication.
• While IFN‑β is also a type I interferon, its production is more broadly distributed among many cell types, whereas IFN‑α is pDC‑centric.

8. Retroviruses and Integration

Definition and Mechanism

A virus that reverse‑transcribes its RNA genome into DNA and then integrates this DNA into the host genome is classified as a retrovirus.

• Reverse transcriptase synthesizes complementary DNA (cDNA) from the viral RNA.
• The viral integrase enzyme inserts the cDNA into the host chromosome, creating a provirus.
• Once integrated, the provirus is transcribed by host RNA polymerase II, producing new viral RNA genomes and proteins.

Human Immunodeficiency Virus (HIV) is the most well‑known retrovirus, illustrating how integration can lead to persistent infection and challenges for eradication.

Conclusion

This course has highlighted key concepts in virology and antiviral immunity, ranging from the molecular requirements of different viral genome types to the sophisticated ways the host detects and responds to infection. Mastery of these topics provides a solid foundation for further study in immunology, infectious disease, and therapeutic development.